Kyntra Bio (KYNB) Gross Margin (2018 - 2026)
Kyntra Bio's (KYNB) quarterly Gross Margin came in at 99.86% in Q2 2026, up 617.0% year-over-year from 13.93% in Q2 2025, and up 1114.38% quarter-over-quarter from 9.84% in Q1 2026.
Powered by 
Analysis
Kyntra Bio (KYNB) Gross Margin (2018 - 2026) Analysis & Trends
Kyntra Bio has disclosed Gross Margin across 9 years of filings, most recently posting 99.86% for Q2 2026.
- In Q2 2026, Gross Margin rose 617.0% year-over-year to 99.86%; the TTM figure through Jun 2026 stood at 41.26% (down 13273.0% YoY), while the FY2025 annual figure was 91.37%, up 4390.0% from the prior year.
- Gross Margin came in at 99.86% for Q2 2026 at Kyntra Bio, up from 9.84% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 286.48% in Q4 2024 to a low of 9.84% in Q1 2026.
- Average Gross Margin over 5 years is 84.05%, with a median of 87.14% recorded in 2023.
- Year-over-year, Gross Margin soared 19932 bps in 2024 and sank 20825 bps in 2025.
- Over 5 years, Gross Margin stood at 41.37% in 2022, then jumped by 111 bps to 87.16% in 2023, then jumped by 229 bps to 286.48% in 2024, then sank by 73 bps to 78.23% in 2025, then climbed by 28 bps to 99.86% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 99.86% in Q2 2026, 9.84% in Q1 2026, and 78.23% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.78 Bn | 192.79 Bn | 7.24 Bn | 72.04% |
| 2 | Gilead Sciences | 179.92 Bn | 176.74 Bn | 6.22 Bn | 79.76% |
| 3 | Vertex Pharmaceuticals | 131.39 Bn | 123.54 Bn | 2.84 Bn | 85.33% |
| 4 | Regeneron Pharmaceuticals | 81.91 Bn | 73.91 Bn | 3.93 Bn | 91.59% |
| 5 | Argenx Se | 60.35 Bn | 55.17 Bn | 1.37 Bn | 90.43% |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | 35.86% |
| 7 | Alnylam Pharmaceuticals | 33.12 Bn | 29.81 Bn | 992.69 Mn | 76.90% |
| 8 | Biogen | 31.92 Bn | 30.63 Bn | 1.96 Bn | 71.60% |
| 9 | Roivant Sciences | 29.23 Bn | 29.23 Bn | 1.16 Mn | 80.31% |
| 10 | Kyntra Bio | 32.08 Mn | 32.08 Mn | 1.47 Mn | 99.86% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.86% |
| Mar 31, 2026 | -9.84% |
| Dec 31, 2025 | 78.23% |
| Sep 30, 2025 | 94.61% |
| Jun 30, 2025 | 93.69% |
| Mar 31, 2025 | 90.80% |
| Dec 31, 2024 | 286.48% |
| Sep 30, 2024 | 39.02% |
| Jun 30, 2024 | 85.97% |
| Mar 31, 2024 | 15.85% |
| Dec 31, 2023 | 87.16% |
| Sep 30, 2023 | 89.43% |
| Jun 30, 2023 | 87.12% |
| Mar 31, 2023 | 90.35% |
| Dec 31, 2022 | 41.37% |
| Sep 30, 2022 | 72.62% |
| Jun 30, 2022 | 77.16% |
| Mar 31, 2022 | 93.03% |
| Dec 31, 2021 | 81.11% |
| Sep 30, 2021 | 97.91% |